HNRNPA3 and amyotrophic lateral sclerosis: Notably, reduced levels of HNRNPA3 protein in C9orf72 ALS cases have been associated with enhanced repeat-dependent toxicity [72] and, more recently, HNRNPA3 has also been described as a modifier of FUS toxicity [73].